Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | LA |
burning on her neck; she developed redness on her neck; she experienced fatigue and a low grad fever; she experienced fatigue and a low grad fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of burning sensation in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 18-JUL-2025, the patient received the 1st dose of Shingrix (left arm). On 18-JUL-2025, less than a day after receiving Shingrix, the patient experienced fever (Verbatim: she experienced fatigue and a low grad fever) and fatigue (Verbatim: she experienced fatigue and a low grad fever). On 25-JUL-2025, the patient experienced burning sensation (Verbatim: burning on her neck) and red neck (Verbatim: she developed redness on her neck). The outcome of the burning sensation and red neck were not resolved and the outcome of the fever and fatigue were resolved. It was unknown if the reporter considered the burning sensation, red neck, fever and fatigue to be related to Shingrix. It was unknown if the company considered the burning sensation, red neck, fever and fatigue to be related to Shingrix. Additional Information: GSK Receipt Date: 25-JUL-2025 The reporter was the patient who received her first dose of Shingrix in her left arm last Friday. The day of the administration she experienced fatigue and a low grad fever. One week later she developed redness and burning on her necks. The reporter stated the redness and burning sensation starts on the left neck and goes all over toward the back.